Robert B. Ostroff, MD
- 2Articles
- 13.1KReads1
- 1999–2018Active
- 6Collaborators
- 275Citations2
About
Robert B. Ostroff, MD, has published research on clinical treatments for major depressive disorder, including the use of ketamine and risperidone augmentation of selective serotonin reuptake inhibitors. His work spans topics in depression and psychiatry, with articles appearing between 1999 and 2018. Ostroff has collaborated frequently with co-authors such as Gerard Sanacora and J. Craig Nelson.
Publications
Ketamine as a Clinical Treatment for Mood Disorders
July 24, 2018
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
